Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Netflix | NFLX | Nov 22, 2024 | 897.79 | +0.03 |
NETGEAR | NTGR | Nov 22, 2024 | 24.30 | +1.63 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Nov 22, 2024 | 44.75 | +0.29 |
NetScout Systems | NTCT | Nov 22, 2024 | 21.81 | +1.16 |
NETSOL Technologies | NTWK | Nov 22, 2024 | 2.68 | +1.52 |
Netstreit | NTST | Nov 22, 2024 | 16.13 | -0.43 |
Network-1 Technologies | NTIP | Nov 22, 2024 | 1.37 | 0.00 |
Neuberger Berman | NML | Nov 22, 2024 | 9.29 | +0.11 |
Neuberger Berman High Yield Strategies Fund | NHS | Nov 22, 2024 | 7.75 | +0.91 |
Neuberger Berman Municipal Fund | NBH | Nov 22, 2024 | 10.67 | -0.09 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Nov 22, 2024 | 13.10 | -0.38 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Nov 22, 2024 | 3.82 | +0.53 |
NeueHealth | NEUE | Nov 22, 2024 | 5.00 | -1.28 |
Neumora Therapeutics | NMRA | Nov 22, 2024 | 9.74 | +0.52 |
Neuraxis | NRXS | Nov 22, 2024 | 3.05 | -2.66 |
Neurobo Pharmaceuticals | NRBO | Nov 22, 2024 | 2.37 | +0.85 |
Neurocrine Biosciences | NBIX | Nov 22, 2024 | 125.65 | +0.52 |
Neurogene | NGNE | Nov 22, 2024 | 20.30 | +30.21 |
NeuroMetrix | NURO | Nov 22, 2024 | 4.25 | +2.41 |
Neuronetics | STIM | Nov 22, 2024 | 0.89 | +5.94 |
NeuroOne | NMTC | Nov 22, 2024 | 0.68 | -2.69 |
Neuropace | NPCE | Nov 22, 2024 | 9.70 | +7.78 |
NeuroSense Therapeutics | NRSN | Nov 22, 2024 | 0.90 | -2.17 |
Nevro | NVRO | Nov 22, 2024 | 4.52 | +3.67 |
New America High Income Fund | HYB | Nov 22, 2024 | 8.27 | +0.12 |
New Concept Energy | GBR | Nov 22, 2024 | 1.22 | +1.67 |
New England Realty Associates LP Unit A | NEN | Nov 22, 2024 | 82.49 | 0.00 |
New Fortress Energy A | NFE | Nov 22, 2024 | 9.75 | +2.52 |
New Found Gold | NFGC | Nov 22, 2024 | 1.64 | +1.23 |
New Germany Fund | GF | Nov 22, 2024 | 7.97 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.